meglumine antimoniate has been researched along with n-vinyl-2-pyrrolidinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa, H; Delgado, G; Gutiérrez, J; Pinzón, J; Vallejo, B | 1 |
| Brígida, RTSS; Diniz Junior, JAP; Gélvez, APC; Rodrigues, APD | 1 |
2 other study(ies) available for meglumine antimoniate and n-vinyl-2-pyrrolidinone
| Article | Year |
|---|---|
In vitro analysis regarding the safety of components used in a film-based therapeutic system loaded with meglumine antimoniate and its activity toward Leishmania major experimental infections: a preliminary study.
Topics: Antiprotozoal Agents; Cell Line; Cell Survival; Chitosan; Cicatrix; Drug Carriers; Excipients; Fibroblasts; Humans; Immunomodulation; Interleukins; Lactic Acid; Leishmania major; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pilot Projects; Povidone; Wound Healing | 2013 |
AgNP-PVP-meglumine antimoniate nanocomposite reduces Leishmania amazonensis infection in macrophages.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; In Vitro Techniques; Leishmania; Macrophages; Meglumine Antimoniate; Metal Nanoparticles; Mice; Mice, Inbred BALB C; Nanocomposites; Povidone; Silver | 2021 |